Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Wolffs (Cardiff, United Kingdom), D. Pass (Cardiff, United Kingdom), B. Mansfield (Cardiff, United Kingdom), R. Bruce (Cardiff, United Kingdom), P. Popov (Cardiff, United Kingdom), C. Corrigan (London, United Kingdom), J. Ward (London, United Kingdom), P. Kemp (Cardiff, United Kingdom), B. Hope-Gill (Cardiff, United Kingdom), D. Riccardi (Cardiff, United Kingdom). Transcriptome profiling reveals a potential role for antagonism of the calcium-sensing receptor in the prophylaxis of idiopathic pulmonary fibrosis. 669

Member's Comments

No comment yet.

Related content which might interest you: Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (5) 1800564; 10.1183/13993003.00564-2018 Year: 2018 Expression of the MET receptor kinase is a potential functional marker of Idiopathic pulmonary fibrosis Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017 Calcium-sensing receptor as a therapeutic target for pulmonary fibrosis Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension? Source: Eur Respir J, 52 (2) 1801287; 10.1183/13993003.01287-2018 Year: 2018 LPA1 antagonists BMS-986020 and BMS-986234 for idiopathic pulmonary fibrosis: Preclinical evaluation of hepatobiliary homeostasis Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 The emerging role of transient receptor potential channels in chronic lung disease Source: Eur Respir J, 50 (2) 1601357; 10.1183/13993003.01357-2016 Year: 2017 Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing Source: ERJ Open Res, 5 (2) 00071-2019; 10.1183/23120541.00071-2019 Year: 2019 Monitoring of liver function in patients with pulmonary hypertension treated with endothelin receptor antagonists: The value of a novel monitoring system Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Effects of a TRPV4 antagonist and pirfenidone on idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Protective roles of mannose receptor in an experimental pulmonary fibrosis model Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 LPA1 antagonist BMS-986278 for idiopathic pulmonary fibrosis: Preclinical pharmacological in vitro and in vivo evaluation Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Blocking endothelin: breaking new ground Source: Eur Respir Rev 2008; 17: 24-29 Year: 2007 Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension Source: Eur Respir J 2016; 48: 470-483 Year: 2016 Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Local expression of hormone receptors seems to play a role in the genesis of idiopathic tracheal stenosis Source: International Congress 2017 – From respiratory muscles to acute respiratory failure Year: 2017 ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020 Year: 2020 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008